Antimicrobial peptide protonectin disturbs the membrane integrity and induces ROS production in yeast cells

Kairong Wang1, Wen Dang1, Junqiu Xie1

  • 1Key Laboratory of Preclinical Study for New Drugs of Gansu Province, School of Basic Medical Sciences, School of Life Sciences, Lanzhou University, 222 Tian Shui South Road, Lanzhou 730000, PR China.

Insights

Antimicrobial peptide protonectin shows strong antifungal and fungicidal activity against fungi. It disrupts cell membranes, induces reactive oxygen species, and inhibits biofilm formation, offering a potential new therapeutic agent for fungal infections.

Area of Science:

  • Microbiology
  • Biochemistry
  • Pharmacology

Background:

  • Candidiasis is a significant cause of bloodstream infections, particularly in immunocompromised individuals.
  • Limited antifungal treatment options necessitate the development of novel therapeutic agents.
  • Antimicrobial peptides (AMPs) present a promising alternative to conventional antibiotics.

Purpose of the Study:

  • To synthesize the antimicrobial peptide protonectin.
  • To evaluate its antifungal activity and fungicidal effects.
  • To elucidate its mechanism of action against fungal cells.

Main Methods:

  • Chemical synthesis of protonectin.
  • Antifungal activity assays against various fungi.
  • Fungicidal activity and mode of action studies, including membrane integrity and reactive oxygen species (ROS) production.
  • Biofilm formation inhibition assays.

Main Results:

  • Protonectin demonstrated potent antifungal and fungicidal activity against tested fungi.
  • The mechanism of action involves disruption of fungal membrane integrity and induction of cellular ROS.
  • Protonectin effectively inhibited biofilm formation and eradicated adherent fungal cells.

Conclusions:

  • Protonectin exhibits significant potential as a therapeutic agent against fungal diseases.
  • Its ability to combat fungal infections, including biofilms, addresses a critical unmet medical need.
  • Protonectin represents a promising novel strategy for treating increasing fungal infections.